Back to Search
Start Over
High-risk stays high-risk: Bruton tyrosine kinase inhibitors in B-cell malignancies.
- Source :
-
Haematologica [Haematologica] 2024 Jul 01; Vol. 109 (7), pp. 2035-2037. Date of Electronic Publication: 2024 Jul 01. - Publication Year :
- 2024
- Subjects :
- Humans
Lymphoma, B-Cell drug therapy
Lymphoma, B-Cell pathology
Leukemia, B-Cell drug therapy
Leukemia, B-Cell pathology
Tyrosine Kinase Inhibitors
Agammaglobulinaemia Tyrosine Kinase antagonists & inhibitors
Protein Kinase Inhibitors therapeutic use
Protein Kinase Inhibitors adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1592-8721
- Volume :
- 109
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Haematologica
- Publication Type :
- Editorial & Opinion
- Accession number :
- 38450529
- Full Text :
- https://doi.org/10.3324/haematol.2024.285029